bernd schlereth: mastering pharmacokinetics and immunogenicity of bispecific antibodies
Published 8 years ago • 1.3K plays • Length 29:22Download video MP4
Download video MP3
Similar videos
-
29:19
sophie tourdot: non-clinical immunogenicity risk assessment of therapeutic proteins
-
11:51
biophysics of antimicrobal peptides - burkhard bechinger
-
1:05:02
reversing thyroid and autoimmune disease with dr. izabella wentz
-
11:02
how to obtain viable cardiomyocytes from resected mouse hearts
-
20:44
bernard maillère: epitope mapping of therapeutic abs in healthy donors to predict immunogenicity
-
35:21
tim hickling: applying in vitro immunogenicity assays to predict clinical immunogenicity
-
33:44
david wraith: antigen-specific tolerance induction: allergy, autoimmunity and anti-drug antibodies
-
36:04
daron forman: the use of immunogenicity risk assessment tools for lead optimization of biologics
-
23:00
john desjarlais: "optimization and application of fc-containing bispecific antibodies"
-
2:07
immunoseq® mouse tcrb assay case study video
-
7:38
the safe and effective use of bis™, pt.1: bis™ value
-
36:05
vibha jawa: risk assessments to drive clinical immunogenicity strategy
-
36:50
tim hickling: contribution of ex vivo assays to immunogenicity risk assessment
-
36:47
robin thorpe: european regulatory guidance for unwanted immunogenicity